Literature DB >> 25057782

Role of an extracellular chaperone, Clusterin in the pathogenesis of Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma.

Biswajit Padhy1, Gargi G Nanda1, Mahasweta Chowdhury2, Debanand Padhi2, Aparna Rao3, Debasmita P Alone4.   

Abstract

Pseudoexfoliation (PEX), an age related disorder is a prominent contributor to secondary glaucoma. Earlier studies have suggested involvement of clusterin in the development of PEX. We designed a case-control study to understand the role of clusterin single nucleotide polymorphisms (SNPs) in PEX and analyzed the role of risk alleles in the disease. Genotyping of SNPs in 136 PEX patients and 89 controls of Indian origin revealed a genetic association between rs2279590 and PEX in Indian population with a p-value of 0.004. The high risk allele "G" at rs2279590 has an effect on clusterin mRNA expression. There was a twofold higher clusterin mRNA level in "GG" genotyped individuals in comparison to "AA" genotyped individuals (p = 0.039). Western blot and immunohistochemistry studies showed an upregulation of Clusterin protein in pseudoexfoliation glaucoma (PXG) affected individuals in both aqueous humor and lens capsules respectively. Together, our results reveal that rs2279590 was found to be associated with PEX in Indian population and the risk allele mediates an allele specific upregulation of the clusterin mRNA. Moreover, upregulation of Clusterin protein in PXG individuals augments further protein deposition.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Indian population; clusterin; glaucoma; pseudoexfoliation

Mesh:

Substances:

Year:  2014        PMID: 25057782     DOI: 10.1016/j.exer.2014.07.005

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  8 in total

Review 1.  Association of clusterin (CLU) variants and exfoliation syndrome: An analysis in two Caucasian studies and a meta-analysis.

Authors:  Bao J Fan; Louis R Pasquale; Jae H Kang; Hani Levkovitch-Verbin; Jonathan L Haines; Janey L Wiggs
Journal:  Exp Eye Res       Date:  2015-08-10       Impact factor: 3.467

2.  Genetics, Diagnosis, and Monitoring of Pseudoexfoliation Glaucoma.

Authors:  Niraj Nathan; Rachel W Kuchtey
Journal:  Curr Ophthalmol Rep       Date:  2016-10-11

3.  De novo variants in an extracellular matrix protein coding gene, fibulin-5 (FBLN5) are associated with pseudoexfoliation.

Authors:  Biswajit Padhy; Ramani Shyam Kapuganti; Bushra Hayat; Pranjya Paramita Mohanty; Debasmita Pankaj Alone
Journal:  Eur J Hum Genet       Date:  2019-07-29       Impact factor: 4.246

Review 4.  A Role for Clusterin in Exfoliation Syndrome and Exfoliation Glaucoma?

Authors:  Janey L Wiggs; Jae Hee Kang; BaoJian Fan; Hani Levkovitch-Verbin; Louis R Pasquale
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

5.  Novel protein constituents of pathological ocular pseudoexfoliation syndrome deposits identified with mass spectrometry.

Authors:  Shiwani Sharma; Tim Chataway; Sonja Klebe; Kim Griggs; Sarah Martin; Nusha Chegeni; Alpana Dave; Tiger Zhou; Maurizio Ronci; Nicolas H Voelcker; Richard A Mills; Jamie E Craig
Journal:  Mol Vis       Date:  2018-12-28       Impact factor: 2.367

6.  CLU Polymorphisms in Patients with Pseudoexfoliation Syndrome in Polish Population.

Authors:  Hanna Lesiewska; Katarzyna Linkowska; Joanna Stafiej; Tomasz Grzybowski; Jacek Swobodziński; Grażyna Malukiewicz
Journal:  J Ophthalmol       Date:  2019-07-01       Impact factor: 1.909

7.  Evaluation of aqueous humor and serum clusterin levels in patients with glaucoma.

Authors:  Fuat Yavrum; Ufuk Elgin; Zeynep Adiyaman Kocer; Vildan Fidanci; Emine Sen
Journal:  BMC Ophthalmol       Date:  2021-01-09       Impact factor: 2.209

8.  Clinical spectrum of pseudoexfoliation syndrome-An electronic records audit.

Authors:  Aparna Rao; Debananda Padhy; Prity Sahay; Amiya Pradhan; Sarada Sarangi; Gopinath Das; Niranjan Raj
Journal:  PLoS One       Date:  2017-10-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.